APPLIED BIOSYSTEMS REPORTS $29.9 MILLION NET INCOME 2ND
QTR.
Applied Biosystems Group (NYSE:ABI), Foster City, Calif., an
Applera Corporation business, has reported that earnings per share in
the second quarter of fiscal 2003, ended December 31, 2002, were . . .
MEDICIS REPORTS $15 MILLION NET INCOME FOR 2ND QTR FISCAL
'03.
Medicis (NYSE:MRX), Scottsdale, Ariz., has announced second quarter
fiscal 2003 net revenues of $59.5 million with net income of $15.3
million, or $0.55 per diluted share, compared to second . . .
VIVUS REPORTS NET LOSS OF $1.6 MILLION FOR 4TH QTR
'02.
VIVUS, Inc. (Nasdaq:VVUS), Mountain View, Calif., a pharmaceutical
company developing innovative products to improve quality of life, has
reported financial results for the three and 12 months . . .
WEIDER REPORTS SECOND QUARTER $12 MILLION NET LOSS.(Weider
Nutrition International Inc.)
Weider Nutrition International, Inc. (NYSE:WNI) has reported
results for the three and six-month periods ended November 30, 2002.
Weider Nutrition's net sales were $64.2 million for the . . .
HARVARD BIOSCIENCE ACQUIRES BTX DIVISION OF
GENETRONICS.(Genetronics Biomedical Corp.)(Brief Article)
Harvard Bioscience, Inc. (Nasdaq NM: HBIO), has signed a definitive
agreement with Genetronics Biomedical Corporation (GEB: AMEX and TSX) to
purchase the non-cash assets of its BTX Division. The . . .
MAXIM REPORTS FOURTH QUARTER NET LOSS OF $11.1 MILLION.(Maxim
Pharmaceuticals Inc.)
Maxim Pharmaceuticals, Inc. (Nasdaq NM: MAXM, SSE: MAXM) has
reported financial results for the fourth quarter and the year ended
September 30, 2002. The net loss applicable to common stock for . . .
ZILA REPORTS 20.7 PERCENT INCREASE IN REVENUE.
Zila, Inc. (Nasdaq:ZILA), has reported strong revenue growth for
the first quarter of its 2003 fiscal year, while restructuring costs and
strategic investments in marketing, product development, . . .
HUTCHINSON REPORTS 4TH QTR NET PROFIT OF OVER $6
MILLION.(Hutchinson Technology Inc.)
Hutchinson Technology Incorporated (Nasdaq:HTCH), Hutchinson,
Minn., has reported a net profit of $6,054,000, or $0.24 per diluted
share, on net sales of $109,122,000 for its fiscal fourth quarter . . .
BRUKER DALTONICS REPORTS 3RD QTR NET INCOME OF $1.7
MILLION.(financial data for Bruker Daltonics Inc.)
Daltonics Inc. (NASDAQ:BDAL), Billerica, Mass., has reported
financial results for its third quarter 2002, and the nine months ended
September 30, 2002.
Third Quarter 2002
For the three months . . .
UNILAB REPORTS 63% INCREASE IN NET INCOME FOR 3RD QTR.(Unilab
Corp.)
Unilab Corporation (Nasdaq:ULAB), Tarzana, Calif., has announced
that net sales for the quarter ended September 30, 2002 were $110.5
million, an increase of 11.5% from $99.0 million in the same . . .
CONCEPTUS REPORTS NET LOSS OF $8.1 MILLION FOR 3RD QTR.(financial
data for Conceptus Inc.)
Conceptus, Inc. (NASDAQ:CPTS), San Carlos, Calif., developer of the
non-incisional permanent birth control procedure Essure(TM), has
announced financial results for the three and nine months . . .
WATERS REPORTS INCREASED THIRD QUARTER SALES.(Waters Corp.)(Brief
Article)
Waters Corporation (NYSE:WAT), Milford, Mass., has reported that
third quarter 2002 sales increased by 4% over prior year levels before
favorable currency effects. After currency effects, reported . . .
BONE CARE INTL. REPORTS INCREASED REVENUES FOR FIRST QTR.
Bone Care International, Inc. (NASDAQ: BCII), Middleton, Wis., has
announced that total revenues for the first quarter ended September 30,
2002 increased to $5.4 million from $2.6 million in the . . .
BIOSPHERE REPORTS 3RD QTR INCREASE IN CONSOLIDATED
REVENUES.(BioSphere Medical Inc.)
BioSphere Medical(TM), Inc. (Nasdaq: BSMD), Rockland, Mass., a
medical device company that is pioneering the use of bioengineered
microspheres to treat hypervascularized tumors and . . .
IDEXX REPORTS 3RD QTR NET INCOME INCREASED 22%.(IDEXX
Laboratories Inc.)
IDEXX Laboratories, Inc. (NASDAQ: IDXX), Westbrook, Maine, has
reported that net income increased 22% to $12.5 million, or $0.36 per
diluted share, for the quarter ended September 30, 2002, . . .
IMMUCELL RETURNS TO PROFITABILITY.
ImmuCell Corporation (NASDAQ: ICCC), Portland, Maine, has announced
a return to profitability and the results of its operations for the
three and nine month periods ended September 30, 2002.
. . .
PRAECIS REPORTS DECREASED NET LOSS FOR QUARTER.(Praecis
Pharmaceuticals Inc.)
Praecis Pharmceuticals, Inc. (NASDAQ: PRCS), Waltham, Mass., has
announced consolidated financial results for the three and nine months
ended September 30, 2002.
The company's net loss for the . . .
PANGEO PHARMA'S 2ND QTR EARNINGS BEFORE INCOME TAXES GROW
106%.(Brief Article)(Statistical Data Included)
PanGeo Pharma, Inc. (TSX:PIL.TO), Montreal, reports 14th
consecutive quarter of comparative net income margin growth
For the second quarter
-- Consolidated revenues for the quarter rise 56% to . . .
COOPER COMPANIES INC. REPORTS 3RD QTR REVENUE UP 48%.(Statistical
Data Included)
The Cooper Companies, Inc. (NYSE:COO), Lake Forest, Calif., has
reported financial results for its third fiscal quarter ended July 31,
2002:
-- Revenue $90.6 million, 48% above third quarter . . .
PRIMEDEX HEALTH SYSTEMS REPORTS 3RD QUARTER LOSS.(Brief
Article)(Statistical Data Included)
Primedex Health Systems, Inc., Los Angeles, Calif., (OTCBB:PMDX),
owner and operator of 52 California medical diagnostic imaging
facilities, has reported a third quarter loss of $5,122,000.
. . .
|
|